Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.
about
Clinical review: sepsis and septic shock--the potential of gene arraysDiagnosing sepsis - The role of laboratory medicine.Biomarker discovery and development in pediatric critical care medicine.Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept.Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock.Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum.Identification of pediatric septic shock subclasses based on genome-wide expression profiling.The pediatric sepsis biomarker risk model.Patient Characteristics, Management, and Predictors of Outcome from Severe Community-Onset Staphylococcal Sepsis in Northeast Thailand: A Prospective Multicenter Study.Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.Pathophysiology and treatment of septic shock in neonates.Leukocyte subset-derived genomewide expression profiles in pediatric septic shockNew approaches to sepsis: molecular diagnostics and biomarkers.Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis.Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shockThe temporal version of the pediatric sepsis biomarker risk model.Validation of a gene expression-based subclassification strategy for pediatric septic shock.Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock.Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers.The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury.Genome-wide expression profiling in pediatric septic shock.Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill childrenCytokine Profiles during Invasive Nontyphoidal Salmonella Disease Predict Outcome in African Children.Bacterial phenotype variants in group B streptococcal toxic shock syndromeCeramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells.Role of biomarkers in sepsis care.IL-8 signaling does not mediate intra-amniotic LPS-induced inflammation and maturation in preterm fetal lamb lung.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model.Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysis.The Value of Admission Serum IL-8 Monitoring and the Correlation with IL-8 (-251A/T) Polymorphism in Critically Ill Patients.Mechanisms and regulation of the gene-expression response to sepsis.Biomarkers for pediatric sepsis and septic shock.Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.Genetics and genomics in pediatric septic shock.Diagnosis and management of hypotension in neonates.Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies.Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.Emerging infection and sepsis biomarkers: will they change current therapies?
P2860
Q26864138-BC70249A-D56B-4AB1-9246-6EC373E3B58CQ30249127-2D26D4F9-CE9B-4A5F-B938-CE774C7BEEB4Q30428168-53B649CF-2AB9-4A90-BA20-120596129C99Q30430434-F87863D9-5E93-440B-85F7-73164630D887Q30433097-333B353F-26DA-4751-820C-034A2B7597AFQ30436233-5D650407-8EC4-4A49-9D3C-FD13ADA9652AQ30438982-80FD04D1-909A-40DC-A9D7-34C9DC3A2CB3Q30540641-57C35D57-0C73-4748-A642-733B09AB94D0Q33636815-F45523FC-E5DE-413C-B90E-82176F2FCF0FQ33901670-5363BCDE-A80A-4981-BD7B-D96DD0BD464DQ33940492-E80BD0AE-271D-479E-ADBF-AC11A78880D7Q34082462-0EF383BD-5E9D-4A34-81AF-F5C048D1B8A2Q34303687-BF8B5B98-42D2-4C9D-90F9-6105791653B9Q34490041-210F6320-7C09-476E-B401-6BC0C70181D2Q34587242-8A296C51-3672-4473-938F-7421D11DEF15Q35120147-FEE3E679-5349-43DA-B367-FB32531DCA80Q35387550-3330813B-E3DE-47E6-A883-D06F513EBEE8Q35946158-BAAC0587-6D17-407C-B123-100DA1043D8DQ36073048-132B6AA3-3871-4210-8AC4-A11DD0D5D65CQ36181988-A410C277-0B69-4AAE-865D-9F8CAA66C55CQ36341842-53B29F24-D9AB-44A8-A370-3B4D254B6293Q36735992-67EFA1EA-4EDF-47AB-BF44-4653F584A4F2Q36928294-5F66F12A-5A33-425F-8732-491733E9C394Q37067282-704C2F22-57BC-4809-95B7-3FA84608BBD3Q37133323-42C425A0-249C-47C9-9326-3F462853B3DAQ37190216-6065D0B8-C4A6-40D2-A00C-F1F8F55D5F63Q37249625-7535EDF8-F82D-4E54-B84F-B4294AAA22FEQ37337516-2BDF5823-25D7-4758-B087-2F19E64A3B1DQ37367885-DD18AE1D-3342-48A0-BB9E-64C3FA60928FQ37529311-E3BB6B32-07B2-4AAA-B5D0-FD83234D0C3EQ37625638-0DB06A62-96CF-43B5-8F67-83FF502B762AQ37657433-ED40F59D-0370-42CC-9BE6-D728D5CFCB68Q37755880-DC44B7FB-51B7-4ECE-9EB3-41DB8CC3B065Q37822454-F661EFA6-0FC9-4967-980C-8631133F40F5Q37858108-5587A1F4-2EC3-4CDB-958E-5BBB9F66BA92Q38003324-D07CB623-2F92-45F6-B6D5-E5001B738180Q38135892-2BF914AB-8836-42DC-9140-73E43F62E57DQ38488118-836553FC-3CBF-4A05-A41A-2E79F51B4E02Q38815368-B3FCA3B3-E2C5-4E31-B1B7-7664E3C1002AQ38929971-7366E031-2A19-4C21-8854-0F112B5270E3
P2860
Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Interleukin-8 as a stratificat ...... olving pediatric septic shock.
@en
type
label
Interleukin-8 as a stratificat ...... olving pediatric septic shock.
@en
prefLabel
Interleukin-8 as a stratificat ...... olving pediatric septic shock.
@en
P2093
P2860
P1476
Interleukin-8 as a stratificat ...... olving pediatric septic shock.
@en
P2093
Derek S Wheeler
Hector R Wong
Kelli Odoms
Marie Monaco
Mark D Williams
Michael T Bigham
Natalie Cvijanovich
William L Macias
P2860
P304
P356
10.1164/RCCM.200801-131OC
P407
P577
2008-05-29T00:00:00Z